Standout Papers
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial (2017)
- Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (2017)
Citation Impact
4 from Science/Nature 59 standout
Citing Papers
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
2024 Standout
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
2024 Standout
Works of Eric Bradford being referenced
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
2020
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
2017 Standout
Author Peers
| Author | Physiology | PRM | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Eric Bradford | 1761 | 1484 | 443 | 48 | 2.1k | |
| Ken Borrelli | 3 | 2 | 1 | 5 | 275 | |
| Dabiao Lu | 1 | 1 | 36 | 390 | ||
| Dhana Lakshmi | 3 | 8 | 3 | 14 | 619 | |
| J. E. King | 6 | 142 | ||||
| Vijaya V. N. Sriram Malladi | 25 | 209 |
All Works
Loading papers...